KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,907,165 | +40.6% | 1,491,489 | +14.0% | 0.00% | +50.0% |
| Q2 2023 | $18,427,102 | +29.2% | 1,308,743 | -1.3% | 0.00% | 0.0% |
| Q1 2023 | $14,265,845 | +57.3% | 1,325,822 | +118.9% | 0.00% | +100.0% |
| Q4 2022 | $9,071,049 | +42.7% | 605,544 | +22.3% | 0.00% | 0.0% |
| Q3 2022 | $6,358,000 | +46.1% | 495,185 | +10.3% | 0.00% | 0.0% |
| Q2 2022 | $4,351,000 | +67.2% | 448,895 | +71.4% | 0.00% | – |
| Q1 2022 | $2,603,000 | -38.0% | 261,845 | -26.6% | 0.00% | -100.0% |
| Q4 2021 | $4,199,000 | +44.3% | 356,764 | +39.7% | 0.00% | – |
| Q3 2021 | $2,909,000 | -45.6% | 255,320 | -33.5% | 0.00% | -100.0% |
| Q2 2021 | $5,348,000 | +62.2% | 383,934 | +115.5% | 0.00% | – |
| Q1 2021 | $3,297,000 | -15.0% | 178,131 | -18.9% | 0.00% | -100.0% |
| Q4 2020 | $3,881,000 | +26.4% | 219,660 | +9.6% | 0.00% | 0.0% |
| Q3 2020 | $3,070,000 | +221.5% | 200,406 | +434.8% | 0.00% | – |
| Q2 2020 | $955,000 | +365.9% | 37,476 | +182.6% | 0.00% | – |
| Q1 2020 | $205,000 | -86.3% | 13,263 | -90.2% | 0.00% | – |
| Q4 2019 | $1,501,000 | +63.0% | 135,752 | +25.4% | 0.00% | – |
| Q3 2019 | $921,000 | +13.1% | 108,234 | +80.1% | 0.00% | – |
| Q2 2019 | $814,000 | +15.8% | 60,098 | +54.2% | 0.00% | – |
| Q1 2019 | $703,000 | +3.5% | 38,968 | +61.3% | 0.00% | – |
| Q4 2018 | $679,000 | +16.9% | 24,160 | +6.2% | 0.00% | – |
| Q3 2018 | $581,000 | +54.5% | 22,758 | +4.8% | 0.00% | – |
| Q2 2018 | $376,000 | – | 21,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |